Stay Updated with the Latest American Funds Invmt Co of Amer R2 RICBX News in Real Time
Find RICBX news now at Meyka AI. Stay informed with the latest American Funds Invmt Co of Amer R2 stocks updates, including price news, market analysis, and expert insights.
Mark Carney Walks Away From US Trade Deal Over French Language Protections, August 25
Mark Carney rejected a US trade deal over French language protections, triggering 50% tariffs on $20 billion in Canadian exports. Canada plans retaliatory tariffs starting September 8.
American Airlines Flight 2398 Laptop Fire Injures Passengers on August 21
American Airlines Flight 2398 experienced a laptop battery fire on August 21, injuring passengers. The FAA has recorded 58 lithium battery incidents this year, raising safety concerns for airlines.
Enflame Plans $892 Million Shanghai IPO, Offering 43 Million Shares as China’s AI Chip Race Heats Up
China’s AI chip race is entering another busy phase as Enflame Technology targets a 6 billion yuan ($892 million) Shanghai IPO. The Tencent-backed chipmaker plans to issue 43.04 million new shares, with subscriptions set to open on September 2, 2026. Price consultations will start on August 28. The offering comes as Chinese AI chipmakers draw…
Federal Judge Voids Trump’s 75-Country Visa Ban on August 23
Federal Judge Jeannette Vargas ruled the Trump administration’s ban on immigrant visas for 75 countries violated the Immigration and Nationality Act of 1952 by discriminating on nationality.
Trump Imposes 50% Tariffs on $20B Canadian Goods as Trade Talks Collapse
Trump imposed 50% tariffs on $20B in Canadian goods after trade talks collapsed. Canada’s PM Carney vowed to match them dollar-for-dollar, triggering a full trade war between the longtime allies.
Fifth Third Backs Payload’s $500M Monthly Payments Platform on August 23
Fifth Third Bank invests in Payload, an embedded payments platform processing $500M monthly. The deal marks Payload’s first outside capital since 2019 and expands payment options across industries.
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.
Egashira 2:50 Donates Disaster Relief Funds on August 22
Egashira 2:50 pledges full donation of flea market sales and merchandise profits to Kumamoto earthquake and Chiba flood victims after clearing 9,720 unsold items from his 2026 festival.
Daniel Mulino Overhauls Super Rules: ATO Gets Veto Power on SMSF Transfers
Assistant Treasurer Daniel Mulino unveils major superannuation reforms including ATO veto power on SMSF transfers, new knowledge requirements, and disclosure rules to protect retirees from switching scams.